Recent Headlines
G2’s FREE, weekly email gives you access to G2 market analysis, regulatory changes, M & A activity, leadership moves and more on the diagnostics industry. Sign up now!
Useful Links
EMERGING TESTS
Inside the Industry: Government Report Casts Doubt on Cost-Effectiveness of Leading Genetic Colorectal Cancer Screening Test
From – Laboratory Industry Report
Few of the newfangled consumer genetic testing products have had greater commercial success and…
G2 Blog
COMPLIANCE
Genetic Testing Fraud Prosecutions are on the Rise around the Country. Are Your Genetic Testing Practices Compliant?
By Robert Liles bio
Over the last year, a number of genetic testing fraud investigations and prosecutions have been initiated by…
REIMBURSEMENT
Medicare Reimbursement: MIPS Bonuses Are Easy to Earn, IF You Can Get into the Program
From – Lab Compliance Advisor
On July 11, CMS announced the results of 2018, Year 2 under the Merit-based Incentive Payment System…
GENETIC TESTING
Genetic Testing: Multigene Panel Testing Detects Hereditary Risk Variants in Metastatic Breast Cancer Patients
From – Diagnostic Testing & Emerging Technologies
The clinical value of performing multigene panel for inherited cancer in patients with metastatic breast cancer has…
FDA
LDTs: FDA Gets Tough with Non-Approved PGx Testing Claims
From – National Intelligence Report
The FDA has apparently set its enforcement sights on Laboratory Developed Tests (LDTs) that claim to predict…